Clinical Trial Update: Anti-CD14 Treatment With IC14 in Hospitalized ARDS Patients [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating IC14 (an anti-CD14 monoclonal antibody) for hospitalized patients with acute respiratory distress syndrome is currently recr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Injury
• Respiratory Distress Syndrome

Drugs mentioned

• IC14

Snippet

Sponsor: Implicit Bioscience | Conditions: Acute Respiratory Distress Syndrome, Adult Respiratory Distress Syndrome | Phase 2 | Status: RECRUITING